Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Biocrates Ink Co-marketing Pact

NEW YORK (GenomeWeb News) – Biocrates Life Sciences said today that it has forged a worldwide co-marketing agreement with Applied Biosystems focused on the metabolomics market.
Innsbruck, Austria-based Biocrates will promote ABI’s mass spectrometers for targeted metabolomics and for use in combination with its AbsoluteIDQ kits. In return, ABI will promote Biocrates’ AbsolteIDQ kits for targeted metabolomics in combination with its triple quadrupole and QTRAP series instruments.
Biocrates launched the AbsoluteIDQ kit at the recent Aanalytica meeting in Munich, Germany. The kits are initially available only in Europe, but the firm plans to expand sales to the US and eventually the rest of the world, it said.
“Metabolomics is a growing field expected to expand the market for mass spectrometers worldwide,” Tamara Bond, senior director of the pharmaceutical business at ABI, said in a statement.
The firms expect to jointly market the combined technologies at upcoming conferences including the American Society of Mass Spectrometry in Denver, Colo., next week.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.